BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Med’s Industry

Johnson And Johnson Expands Acuvue Oasys Max Daily Contact Lens Portfolio In Singapore

The brand also expands daily disposable options for astigmatic adults with the launch of ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, bringing pioneer...

February 11, 2026 | News

Innovate UK Funds AI Platform To Predict Hospital Infections Up To Seven Days Earlier

Funding supports the co-design and roll-out of MEMORI, a Class IIb CE-certified SaMD platform, tailored to local clinical teams and systems ME...

February 11, 2026 | News

China Approves Promega OncoMate MSI Companion Diagnostic For KEYTRUDA Therapy

The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vi...

February 06, 2026 | News

Innovations In Magnetic Resonance Imaging Introduced By United Imaging

Tomorrow's technology. Artificial intelligence and the uCS platform The key to the innovations introduced by United Imaging is the combination of advanced...

February 05, 2026 | News

Akso Health Group Launches Exploratory Global Patient Support Programme With Nanning Duoling Research Institute To Expand Zero Cost Cancer Care Access

Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") announced the launch of the an exploratory patient support program and a strategic coopera...

February 05, 2026 | News

ZEISS Secures NMPA Approval For ARTEVO 750 And ARTEVO 850 Ophthalmic Surgical Microscopes In China

ZEISS ARTEVO 750 and ZEISS ARTEVO 850 surgical microscopes provide ophthalmic surgeons in China with end-to-end workflow integration to improve efficiency,...

February 04, 2026 | News

Ascletis Pharma Reports Positive Phase III Safety Results For Denifanstat In Moderate To Severe Acne

Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label ...

February 03, 2026 | News

Turning Frontline Reality Into Policy Action For Cancer Care In Asia

Drawing on her frontline clinical experience in Malaysia, Prof Dr Wan Zamaniah, Consultant Clinical Oncologist, University Malaya Medical Centre&...

February 02, 2026 | Expert Insight

China Approves World First cAMP Biased GLP One Receptor Agonist For Type Two Diabetes

Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic disea...

February 02, 2026 | News

China Originated Innovation Is Rising. Global Expectations Are Rising Even Faster.

The momentum is real—and so is the level of scrutiny. As more programs move beyond regional boundaries, expectations from global biopharma companies ...

February 02, 2026 | News | By Anil Kane, executive director, global head of technical and scientific affairs, Thermo Fisher Scientific

China Approves First Ever Therapy For Chronic Hepatitis D With Conditional Clearance For Libevitug

Huahui Health announced that China's National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for chroni...

January 28, 2026 | News

Japan Tissue Engineering Co Secures National Insurance Reimbursement For JACC In Knee Osteoarthritis

-Japan Tissue Engineering Co., Ltd.（J-TEC） announced that JACC, its autologous cultured cartilage product, has been granted approval by Japan&rsqu...

January 28, 2026 | News

BioMed X Launches EU Backed AI Precision Medicine Project With Barbados To Address Early Diabetic Kidney Disease

The new project, supported by the European Union’s PharmaNext Programme, focuses on population-specific molecular profiling and AI-driven precision m...

January 28, 2026 | News

Merz Therapeutics Submits XEOMIN For Paediatric Spasticity Indication Across Europe

Merz Therapeutics, a leading player in neurology-focused specialty pharma, announced that it has completed the regulatory submission for XEOMIN®&...

January 27, 2026 | News

Stay Connected